Drug Database
Back to search

Belgium· BE-AMP-SAM209806-00

Teveten 600 mg

A eprosartan product containing eprosartan mesilate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 8 of our 19 countries.

ATC C09CA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTeveten 600 mgATCC09CA02REGISTER NO.BE-AMP-SAM209806-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eprosartan mesilateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eprosartan is registered in 8 of 19 countries.

Countries holding a registration under ATC C09CA02 (eprosartan), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search eprosartan products by name

Eprosartan · ATC C09CA02

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eprosartan costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Eprosartan · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • ES Spain$0.58
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Eprosartan Mesilate
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
C09CA02
ATC class
Eprosartan
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

1 priced
  • be_apb
    0765016
  • be_apb
    1550193
  • be_apb
    1727064
    EUR 52.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for eprosartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eprosartan against other medicinesHow interaction checks work

Eprosartan · interactions on record

201 records

  • 7 severe
  • 113 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eprosartan in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eprosartan products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Teveten
  • Bulgaria · Теветен
  • Germany · Eprosartan Amarox, Eprosartan Ratiopharm
  • Spain · Futuran, Navixen
  • Finland · Teveten
  • United Kingdom (Northern Ireland) · Eprosartan Activase Pharmaceuticals, Eprosartan Amarox
  • Greece · Teveten
  • Ireland · Teveten
  • Luxembourg · Teveten
  • Netherlands · Teveten
  • Norway · Teveten
  • Portugal · Teveten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5eea0407-3121-43d0-9747-c605dcaa246e
GET /v1/drugs/5eea0407-3121-43d0-9747-c605dcaa246e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Teveten 600 mg",
  "name_fr": "Teveten 600 mg",
  "name_nl": "Teveten 600 mg",
  "amp_code": "SAM209806-00",
  "strengths": [
    "735.8000",
    "735.8000",
    "600.0000",
    "600.0000",
    "43.3000"
  ],
  "pack_count": 6,
  "substances": [
    "Eprosartan Mesilate",
    "Eprosartan",
    "Lactose Monohydrate",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Eprosartan",
  "authorisation_numbers": [
    "BE209806",
    "BE209815"
  ]
}
API referenceMCP serverPlans

See everything about eprosartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console